Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $81.4 Million. That's 2.49% of their equity portfolio (11th largest holding). The investor owns 1.18% of the outstanding Verona Pharma Plc stock. The stake costed the investor $31.3 Million, netting the investor a gain of 160% so far.